Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy
Doroshow, D. B. et al. PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Nat. Rev. Clin. Oncol. 18, 345–362 (2021).
Google Scholar
Nutsch, K. et al. TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation. Nat. Cancer 5, 1834–1851 (2024).
Google Scholar
van Gulijk, M. et al. PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Sci. Immunol. 8, eabn6173 (2023).
Google Scholar
Fu, J. et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci. Transl. Med. 7, 283ra252 (2015).
Google Scholar
Wu, J. et al. A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies. Cell Rep. Med. 5, 101747 (2024).
Google Scholar
Sun, J.-Y. et al. Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomark. Res. 8, 35 (2020).
Google Scholar
Lu, Y. et al. An OMV-based nanovaccine as antigen presentation signal enhancer for cancer immunotherapy. Adv. Mater. 37, e2413392 (2025).
Google Scholar
Maggiorani, D. et al. Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment. Nat. Commun. 15, 2435 (2024).
Google Scholar
Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 (2018).
Google Scholar
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G. & Jain, R. K. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat. Rev. Clin. Oncol. 15, 325–340 (2018).
Google Scholar
Guelfi, S., Hodivala-Dilke, K. & Bergers, G. Targeting the tumour vasculature: from vessel destruction to promotion. Nat. Rev. Cancer 24, 655–675 (2024).
Google Scholar
Guo, L. et al. Enhanced pericyte-endothelial interactions through NO-boosted extracellular vesicles drive revascularization in a mouse model of ischemic injury. Nat. Commun. 14, 7334 (2023).
Google Scholar
Huang, Y. et al. Improving immune–vascular crosstalk for cancer immunotherapy. Nat. Rev. Immunol. 18, 195–203 (2018).
Google Scholar
Sun, Y. et al. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy. Sci. Transl. Med. 13, eabc8922 (2021).
Google Scholar
Tichet, M. et al. Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages. Immunity 56, 162–179 (2023).
Google Scholar
Steeg, P. S. The blood−tumour barrier in cancer biology and therapy. Nat. Rev. Clin. Oncol. 18, 696–714 (2021).
Google Scholar
Roolfs, L. et al. Therapeutic approaches targeting vascular repair after experimental spinal cord injury: a systematic review of the literature. Neurospine 19, 961–975 (2022).
Google Scholar
Choi, Y. & Jung, K. Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy. Exp. Mol. Med. 55, 2308–2319 (2023).
Google Scholar
Bae, J. et al. IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer. Nat. Cell Biol. 24, 1754–1765 (2022).
Google Scholar
Zhang, X. et al. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells. Cancer Cell 40, 1407–1422 (2022).
Google Scholar
Foy, S. P. et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615, 687–696 (2023).
Google Scholar
Bogdan, C. Nitric oxide and the immune response. Nat. Immunol. 2, 907–916 (2001).
Google Scholar
Lin, M. et al. MCM8-mediated mitophagy protects vascular health in response to nitric oxide signaling in a mouse model of Kawasaki disease. Nat. Cardiovasc. Res. 2, 778–792 (2023).
Google Scholar
Fukumura, D., Kashiwagi, S. & Jain, R. K. The role of nitric oxide in tumour progression. Nat. Rev. Cancer 6, 521–534 (2006).
Google Scholar
García-Ortiz, A. & Serrador, J. M. Nitric oxide signaling in T cell-mediated immunity. Trends Mol. Med. 24, 412–427 (2018).
Google Scholar
Zheng, J. H. et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci. Transl. Med. 9, eaak9537 (2017).
Google Scholar
Kim, J. et al. Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy. Nat. Commun. 13, 1479 (2022).
Google Scholar
Zhang, L. et al. NO-enhanced sonodynamic nanovesicles with co-stimulatory molecule self-presentation for multidimensional tumor immunotherapy. Angew. Chem. Int. Ed. Engl. 64, e202504684 (2025).
Google Scholar
Huang, H. C. et al. Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours. Gut 71, 1843–1855 (2022).
Google Scholar
Yue, Y. et al. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria. Nat. Biomed. Eng. 6, 898–909 (2022).
Google Scholar
An, J. X. et al. Bacteria-based backpacks to enhance adoptive macrophage transfer against solid tumors. Adv. Mater. 36, e2305384 (2024).
Google Scholar
Han, Z. Y. et al. Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer. Nat. Commun. 15, 7096 (2024).
Google Scholar
Yin, T. et al. Engineering bacteria and bionic bacterial derivatives with nanoparticles for cancer therapy. Small 18, e2104643 (2022).
Google Scholar
Kuypers, M. M. M., Marchant, H. K. & Kartal, B. The microbial nitrogen-cycling network. Nat. Rev. Microbiol. 16, 263–276 (2018).
Google Scholar
Chen, B. et al. Surface programmed bacteria as photo-controlled NO generator for tumor immunological and gas therapy. J. Control. Release 353, 889–902 (2023).
Google Scholar
Wang, L. et al. Hybridized and engineered microbe for catalytic generation of peroxynitrite and cancer immunotherapy under sonopiezo initiation. Sci. Adv. 10, eadp7540 (2024).
Google Scholar
Canale, F. P. et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature 598, 662–666 (2021).
Google Scholar
Johnson, G. E., Lalanne, J. B., Peters, M. L. & Li, G. W. Functionally uncoupled transcription−translation in Bacillus subtilis. Nature 585, 124–128 (2020).
Google Scholar
Holden, J. K. et al. Structural and biological studies on bacterial nitric oxide synthase inhibitors. Proc. Natl Acad. Sci. USA 110, 18127–18131 (2013).
Google Scholar
Earl, A. M., Losick, R. & Kolter, R. Ecology and genomics of Bacillus subtilis. Trends Microbiol. 16, 269–275 (2008).
Google Scholar
Kinkel, T. L. et al. An essential role for bacterial nitric oxide synthase in Staphylococcus aureus electron transfer and colonization. Nat. Microbiol. 2, 16224 (2016).
Google Scholar
Mogen, A. B. et al. Staphylococcus aureus nitric oxide synthase (saNOS) modulates aerobic respiratory metabolism and cell physiology. Mol. Microbiol. 105, 139–157 (2017).
Google Scholar
Shu, X., Shi, Y., Huang, Y., Yu, D. & Sun, B. Transcription tuned by S-nitrosylation underlies a mechanism for Staphylococcus aureus to circumvent vancomycin killing. Nat. Commun. 14, 2318 (2023).
Google Scholar
Rajagopal, B. S., DePonte, J. 3rd, Tuchman, M. & Malamy, M. H. Use of inducible feedback-resistant N-acetylglutamate synthetase (argA) genes for enhanced arginine biosynthesis by genetically engineered Escherichia coli K-12 strains. Appl. Environ. Microbiol. 64, 1805–1811 (1998).
Google Scholar
Jiang, W. et al. Nitric oxide induces immunogenic cell death and potentiates cancer immunotherapy. ACS Nano 16, 3881–3894 (2022).
Google Scholar
Fang, X. et al. Photogenerated holes mediated nitric oxide production for hypoxic tumor treatment. Angew. Chem. Int. Ed. Engl. 60, 7046–7050 (2021).
Google Scholar
Wang-Bishop, L. et al. STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy. Sci. Immunol. 8, eadd1153 (2023).
Google Scholar
van der Woude, L. L., Gorris, M. A. J., Halilovic, A., Figdor, C. G. & de Vries, I. J. M. Migrating into the tumor: a roadmap for T cells. Trends Cancer 3, 797–808 (2017).
Google Scholar
Liu, H., Hou, Y., Wang, Y. & Li, Z. Enhancement of sulfur conversion rate in the production of L-cysteine by engineered Escherichia coli. J. Agric. Food Chem. 68, 250–257 (2020).
Google Scholar
Chen, Y. et al. Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine. Cell Rep. Med. 6, 101877 (2025).
Google Scholar
Pei, Z. et al. A metal anion strategy to induce pyroptosis combined with STING activation to synergistically amplify anti-tumor immunity. Mater. Today 80, 23–39 (2024).
Google Scholar
You, Y. et al. Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy. Nat. Biomed. Eng. 7, 887–900 (2023).
Google Scholar
Wu, L. et al. Smart lipid nanoparticle that remodels tumor microenvironment for activatable H2S gas and photodynamic immunotherapy. J. Am. Chem. Soc. 145, 27838–27849 (2023).
Google Scholar
Wang, Y. et al. Bioinspired lipoproteins of furoxans-oxaliplatin remodel physical barriers in tumor to potentiate T-cell infiltration. Adv. Mater. 34, e2110614 (2022).
Google Scholar
Wang, G. et al. Enzyme-triggered transcytosis of dendrimer−drug conjugate for deep penetration into pancreatic tumors. ACS Nano 14, 4890–4904 (2020).
Google Scholar
Sung, Y. C. et al. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies. Nat. Nanotechnol. 14, 1160–1169 (2019).
Google Scholar
Cantelmo, A. R. et al. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy. Cancer Cell 30, 968–985 (2016).
Google Scholar
Sugahara, K. N. et al. Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell 16, 510–520 (2009).
Google Scholar
Xu, Z. et al. Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization. Nat. Commun. 12, 6310 (2021).
Google Scholar
Meng, Y. M. et al. Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities. Nat. Commun. 12, 6011 (2021).
Google Scholar
Lv, H. et al. TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer. Nat. Commun. 15, 6 (2024).
Google Scholar
Conniot, J. et al. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nat. Nanotechnol. 14, 891–901 (2019).
Google Scholar
Talwar, D. et al. The GAPDH redox switch safeguards reductive capacity and enables survival of stressed tumour cells. Nat. Metab. 5, 660–676 (2023).
Google Scholar
Luo, T., Chen, M., He, H., Jiang, T. & Dong, J. The application of contrast-enhanced ultrasound and MicroFlow Imaging in the diagnosis of breast cancer. J. Med. Ultrason. (2001) 52, 245–251 (2025).
Google Scholar
Xu, S. et al. Transcriptomic analyses of MC38 tumors following ECN-NO treatment. BioProject https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1240646/ (2025).
Zhang, T. et al. Sustained NO production by engineered bacteria: a dual strategy of tumor vasculature normalization and T-cell exhaustion reversal for robust immunotherapy. BioProject https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1240685/ (2025).
